PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate-Reference-Cited by-同舟云学术

PTEN Protein Loss and Clinical Outcome from Castration-resistant Prostate Cancer Treated with Abiraterone Acetate

Published:2015-04 Issue:4 Volume:67 Page:795-802
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Ferraldeschi Roberta,Nava Rodrigues Daniel,Riisnaes Ruth,Miranda Susana,Figueiredo Ines,Rescigno Pasquale,Ravi Praful,Pezaro Carmel,Omlin Aurelius,Lorente David,Zafeiriou Zafeiris,Mateo Joaquin,Altavilla Amelia,Sideris Spyridon,Bianchini Diletta,Grist Emily,Thway Khin,Perez Lopez Raquel,Tunariu Nina,Parker Chris,Dearnaley David,Reid Alison,Attard Gerhardt,de Bono Johann

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012;Ferlay;Eur J Cancer,2013

2. New strategies in prostate cancer: translating genomics into the clinic;Beltran;Clin Cancer Res,2013

3. Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer;Cuzick;Br J Cancer,2013

4. Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis;Schmitz;Int J Cancer,2007

5. Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer;Carver;Cancer Cell,2011

Cited by 205 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity;Proceedings of the National Academy of Sciences;2024-07-25

2. Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers;JAMA Network Open;2024-07-18

3. Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial;European Journal of Cancer;2024-07

4. Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial;Clinical Cancer Research;2024-05-24

5. Plasma microRNA Signature as Companion Diagnostic for Abiraterone Acetate Treatment in Metastatic Castration-Resistant Prostate Cancer: A Pilot Study;International Journal of Molecular Sciences;2024-05-21